228 related articles for article (PubMed ID: 20046582)
1. Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer.
Krishnan AV; Srinivas S; Feldman D
Dermatoendocrinol; 2009 Jan; 1(1):7-11. PubMed ID: 20046582
[TBL] [Abstract][Full Text] [Related]
2. Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer.
Krishnan AV; Moreno J; Nonn L; Malloy P; Swami S; Peng L; Peehl DM; Feldman D
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):694-702. PubMed ID: 17229571
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.
Moreno J; Krishnan AV; Peehl DM; Feldman D
Anticancer Res; 2006; 26(4A):2525-30. PubMed ID: 16886660
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity.
Krishnan AV; Moreno J; Nonn L; Swami S; Peehl DM; Feldman D
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V74-80. PubMed ID: 18290727
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
Krishnan AV; Feldman D
Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer.
Swami S; Krishnan AV; Moreno J; Bhattacharyya RB; Peehl DM; Feldman D
J Nutr; 2007 Jan; 137(1 Suppl):205S-210S. PubMed ID: 17182827
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer.
Moreno J; Krishnan AV; Feldman D
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):31-6. PubMed ID: 16024246
[TBL] [Abstract][Full Text] [Related]
8. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
Swami S; Krishnan AV; Moreno J; Bhattacharyya RS; Gardner C; Brooks JD; Peehl DM; Feldman D
Int J Cancer; 2009 May; 124(9):2050-9. PubMed ID: 19127598
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of calcitriol and naproxen in recurrent prostate cancer.
Srinivas S; Feldman D
Anticancer Res; 2009 Sep; 29(9):3605-10. PubMed ID: 19667155
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer--new aspects of tumor biology: are calcitriol and cyclooxygenase-2 possible targets for breast cancer?
Thill M; Terjung A; Friedrich M
Eur J Gynaecol Oncol; 2014; 35(4):341-58. PubMed ID: 25118473
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):343-8. PubMed ID: 20156557
[TBL] [Abstract][Full Text] [Related]
13. The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinoma.
Lin DW; Nelson PS
Clin Prostate Cancer; 2003 Sep; 2(2):119-26. PubMed ID: 15040874
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.
Krishnan AV; Feldman D
Annu Rev Pharmacol Toxicol; 2011; 51():311-36. PubMed ID: 20936945
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence.
Müller-Decker K
Cancer Metastasis Rev; 2011 Dec; 30(3-4):343-61. PubMed ID: 22038018
[TBL] [Abstract][Full Text] [Related]
16. [Role of prostaglandins in colon cancer].
Myung SJ; Kim IH
Korean J Gastroenterol; 2008 May; 51(5):274-9. PubMed ID: 18516010
[TBL] [Abstract][Full Text] [Related]
17. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy.
Krishnan AV; Swami S; Peng L; Wang J; Moreno J; Feldman D
Endocrinology; 2010 Jan; 151(1):32-42. PubMed ID: 19906814
[TBL] [Abstract][Full Text] [Related]
18. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
Nayak NR; Sengupta J; Ghosh D
Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandins, their inhibitors and cancer.
Lupulescu A
Prostaglandins Leukot Essent Fatty Acids; 1996 Feb; 54(2):83-94. PubMed ID: 8848435
[TBL] [Abstract][Full Text] [Related]
20. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]